Zipp F - Search Results

1

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.

Gracien RM, Jurcoane A, Wagner M, Reitz SC, Mayer C, Volz S, Hof SM, Fleischer V, Droby A, Steinmetz H, Zipp F, Hattingen E, Deichmann R, Klein JC. Gracien RM, et al. Among authors: zipp f. PLoS One. 2016 Aug 11;11(8):e0161036. doi: 10.1371/journal.pone.0161036. eCollection 2016. PLoS One. 2016. PMID: 27513853 Free PMC article.

2

A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.

Zipp F. Zipp F. J Neurol Sci. 2009 Dec;287 Suppl 1:S24-9. doi: 10.1016/S0022-510X(09)71297-3. J Neurol Sci. 2009. PMID: 20106345 Review.

3

Multiple sclerosis - candidate mechanisms underlying CNS atrophy.

Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Siffrin V, et al. Among authors: zipp f. Trends Neurosci. 2010 Apr;33(4):202-10. doi: 10.1016/j.tins.2010.01.002. Epub 2010 Feb 12. Trends Neurosci. 2010. PMID: 20153532 Review.

4

MRI pattern recognition in multiple sclerosis normal-appearing brain areas.

Weygandt M, Hackmack K, Pfüller C, Bellmann-Strobl J, Paul F, Zipp F, Haynes JD. Weygandt M, et al. Among authors: zipp f. PLoS One. 2011;6(6):e21138. doi: 10.1371/journal.pone.0021138. Epub 2011 Jun 17. PLoS One. 2011. PMID: 21695053 Free PMC article.

5

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.

Chanvillard C, Millward JM, Lozano M, Hamann I, Paul F, Zipp F, Dörr J, Infante-Duarte C. Chanvillard C, et al. Among authors: zipp f. PLoS One. 2012;7(6):e39625. doi: 10.1371/journal.pone.0039625. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768101 Free PMC article. Clinical Trial.

6

Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.

Trinschek B, Luessi F, Haas J, Wildemann B, Zipp F, Wiendl H, Becker C, Jonuleit H. Trinschek B, et al. Among authors: zipp f. PLoS One. 2013 Oct 14;8(10):e77634. doi: 10.1371/journal.pone.0077634. eCollection 2013. PLoS One. 2013. PMID: 24155968 Free PMC article.

7

Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.

Fleischer V, Salmen A, Kollar S, Weyer V, Siffrin V, Chan A, Zipp F, Luessi F. Fleischer V, et al. Among authors: zipp f. J Clin Neurol. 2014 Oct;10(4):289-95. doi: 10.3988/jcn.2014.10.4.289. Epub 2014 Oct 6. J Clin Neurol. 2014. PMID: 25324877 Free PMC article.

8

Remyelinating strategies in multiple sclerosis.

Luessi F, Kuhlmann T, Zipp F. Luessi F, et al. Among authors: zipp f. Expert Rev Neurother. 2014 Nov;14(11):1315-34. doi: 10.1586/14737175.2014.969241. Expert Rev Neurother. 2014. PMID: 25331418 Review.

9

Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: a multi-center, retrospective analysis.

Grey Née Cotte S, Salmen Née Stroet A, von Ahsen N, Starck M, Winkelmann A, Zettl UK, Comabella M, Montalban X, Zipp F, Fleischer V, Kruse N, Gold R, Chan A. Grey Née Cotte S, et al. Among authors: zipp f. J Neuroimmunol. 2015 Jan 15;278:277-9. doi: 10.1016/j.jneuroim.2014.11.017. Epub 2014 Nov 20. J Neuroimmunol. 2015. PMID: 25468777

10

A human post-mortem brain model for the standardization of multi-centre MRI studies.

Droby A, Lukas C, Schänzer A, Spiwoks-Becker I, Giorgio A, Gold R, De Stefano N, Kugel H, Deppe M, Wiendl H, Meuth SG, Acker T, Zipp F, Deichmann R. Droby A, et al. Among authors: zipp f. Neuroimage. 2015 Apr 15;110:11-21. doi: 10.1016/j.neuroimage.2015.01.028. Epub 2015 Jan 14. Neuroimage. 2015. PMID: 25595502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters